PLx Pharma Winddown Corp.
PLXPQ
OTC PK
| 09/30/2022 | 06/30/2022 | ||||
|---|---|---|---|---|---|
| Revenue | -20.08% | -76.81% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -20.08% | -76.81% | |||
| Cost of Revenue | 78.05% | -29.85% | |||
| Gross Profit | -218.69% | -136.87% | |||
| SG&A Expenses | -33.00% | -26.07% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -25.27% | -25.93% | |||
| Operating Income | 25.44% | 20.10% | |||
| Income Before Tax | 28.34% | -9.95% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 28.34% | -9.95% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 28.34% | -9.95% | |||
| EBIT | 25.44% | 20.10% | |||
| EBITDA | 25.50% | 20.14% | |||
| EPS Basic | 30.62% | -9.35% | |||
| Normalized Basic EPS | 30.61% | -9.31% | |||
| EPS Diluted | 30.62% | -9.35% | |||
| Normalized Diluted EPS | 30.61% | -9.31% | |||
| Average Basic Shares Outstanding | 3.29% | 0.56% | |||
| Average Diluted Shares Outstanding | 3.29% | 0.56% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||